Search

Author/Creator Domchek, Susan M

1. A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale. (February 2017)

Authors:
Isakoff, Steven J; Puhalla, Shannon; Domchek, Susan M; Friedlander, Michael; Kaufman, Bella; Robson, Mark; Telli, Melinda L; Diéras, Véronique; Han, Hyo Sook; Garber, Judy E; Johnson, Eric F; Maag, David; Qin, Qin; Giranda, Vincent L; Shepherd, Stacie P
Journal:
Future oncology
Issue:
Volume 13:Number 4(2017)
Page Start:
307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety. Issue 9 (3rd November 2019)

Authors:
Kristeleit, Rebecca S; Oaknin, Ana; Ray-Coquard, Isabelle; Leary, Alexandra; Balmaña, Judith; Drew, Yvette; Oza, Amit M; Shapira-Frommer, Ronnie; Domchek, Susan M; Cameron, Terri; Maloney, Lara; Goble, Sandra; Lorusso, Domenica; Ledermann, Jonathan A; McNeish, Iain A
Journal:
International journal of gynecological cancer
Issue:
Volume 29:Issue 9(2019)
Page Start:
1396
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety. Issue 9 (November 2019)

Authors:
Kristeleit, Rebecca S; Oaknin, Ana; Ray-Coquard, Isabelle; Leary, Alexandra; Balmaña, Judith; Drew, Yvette; Oza, Amit M; Shapira-Frommer, Ronnie; Domchek, Susan M; Cameron, Terri; Maloney, Lara; Goble, Sandra; Lorusso, Domenica; Ledermann, Jonathan A; McNeish, Iain A
Journal:
International journal of gynecological cancer
Issue:
Volume 29:Issue 9(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. Issue 8 (12th August 2012)

Authors:
Spurdle, Amanda B; Whiley, Phillip J; Thompson, Bryony; Feng, Bingjian; Healey, Sue; Brown, Melissa A; Pettigrew, Christopher; Van Asperen, Christi J; Ausems, Margreet G E M; Kattentidt-Mouravieva, Anna A; van den Ouweland, Ans M W; Belgium UV Consortium, Dutch; Lindblom, Annika; Pigg, Maritta H;...
Journal:
Journal of medical genetics
Issue:
Volume 49:Issue 8(2012)
Page Start:
525
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores. (28th July 2021)

Authors:
Barnes, Daniel R; Silvestri, Valentina; Leslie, Goska; McGuffog, Lesley; Dennis, Joe; Yang, Xin; Adlard, Julian; Agnarsson, Bjarni A; Ahmed, Munaza; Aittomäki, Kristiina; Andrulis, Irene L; Arason, Adalgeir; Arnold, Norbert; Auber, Bernd; Azzollini, Jacopo; Balmaña, Judith; Barkardottir, Rosa B; ...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 114:Number 1(2022)
Page Start:
109
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women. (19th May 2020)

Authors:
Palmer, Julie R; Polley, Eric C; Hu, Chunling; John, Esther M; Haiman, Christopher; Hart, Steven N; Gaudet, Mia; Pal, Tuya; Anton-Culver, Hoda; Trentham-Dietz, Amy; Bernstein, Leslie; Ambrosone, Christine B; Bandera, Elisa V; Bertrand, Kimberly A; Bethea, Traci N; Gao, Chi; Gnanaolivu, Rohan D; H...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 112:Number 12(2020)
Page Start:
1213
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. (12th October 2018)

Authors:
Qian, Frank; Wang, Shengfeng; Mitchell, Jonathan; McGuffog, Lesley; Barrowdale, Daniel; Leslie, Goska; Oosterwijk, Jan C; Chung, Wendy K; Evans, D Gareth; Engel, Christoph; Kast, Karin; Aalfs, Cora M; Adank, Muriel A; Adlard, Julian; Agnarsson, Bjarni A; Aittomäki, Kristiina; Alducci, Elisa; Andr...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 111:Number 4(2019)
Page Start:
350
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial. Issue 8 (August 2022)

Authors:
Reiss, Kim A; Mick, Rosemarie; Teitelbaum, Ursina; O'Hara, Mark; Schneider, Charles; Massa, Ryan; Karasic, Thomas; Tondon, Rashmi; Onyiah, Chioma; Gosselin, Mary Kate; Donze, Alyssa; Domchek, Susan M; Vonderheide, Robert H
Journal:
Lancet oncology
Issue:
Volume 23:Issue 8(2022)
Page Start:
1009
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study. Issue 9 (September 2020)

Authors:
Domchek, Susan M; Postel-Vinay, Sophie; Im, Seock-Ah; Park, Yeon Hee; Delord, Jean-Pierre; Italiano, Antoine; Alexandre, Jerome; You, Benoit; Bastian, Sara; Krebs, Matthew G; Wang, Ding; Waqar, Saiama N; Lanasa, Mark; Rhee, Joon; Gao, Haiyan; Rocher-Ros, Vidalba; Jones, Emma V; Gulati, Sakshi; Co...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 9(2020)
Page Start:
1155
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗